Highly active antiretroviral therapy (HAART) and prolonged survival of a patient with an HIV-related Burkitt lymphoma, despite an intracardiac relapse

被引:6
作者
Brinkman, K
Delnoy, PP
de Pauw, B
机构
[1] Univ Nijmegen Hosp, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen Hosp, Dept Cardiol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen Hosp, Dept Haematol, NL-6500 HB Nijmegen, Netherlands
关键词
HIV; Burkitt lymphoma; cardiac manifestation; survival;
D O I
10.1258/0956462981921404
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:773 / 775
页数:3
相关论文
共 50 条
  • [21] Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy
    Antinori, A
    Cingolani, A
    Alba, L
    Ammassari, A
    Serraino, D
    Ciancio, BC
    Palmieri, F
    De Luca, A
    Larocca, LM
    Ruco, L
    Ippolito, G
    Cauda, R
    AIDS, 2001, 15 (12) : 1483 - 1491
  • [22] Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil
    Lima da Silva, Carlos Alberto
    Dourado, Ines
    Dahia, Samir Resack
    Harzheim, Erno
    Rutherford, George Williams
    JOURNAL OF PUBLIC HEALTH DENTISTRY, 2008, 68 (03) : 178 - 181
  • [23] Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study
    Nuvoli, S.
    Caruana, G.
    Babudieri, S.
    Solinas, P.
    Pellicano, G.
    Piras, B.
    Fiore, V.
    Bagella, P.
    Calia, G. M.
    Yue, M.
    Spanu, A.
    Madeddu, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (06) : 1852 - 1859
  • [24] Impact of Highly Active Antiretroviral Therapy (HAART) on Organs of HIV Infected Children in Abia State, Nigeria
    Ajulo, M. O.
    Omole, M. K.
    Moody, J. O.
    BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 4 (07): : 837 - 848
  • [25] Significant decrease of the enhancement/neutralization index in HIV patients during highly active antiretroviral therapy (HAART)
    Bánhegyi, D
    Bácsi, A
    Tóth, FD
    Prohászka, Z
    Horváth, A
    Beck, Z
    Kónya, J
    Füst, G
    IMMUNOLOGY LETTERS, 2003, 89 (01) : 25 - 30
  • [26] Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)
    Maschke, M
    Kastrup, O
    Esser, S
    Ross, B
    Hengge, U
    Hufnagel, A
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (03) : 376 - 380
  • [27] HIV/AIDS patient satisfaction with hospitalization in the era of highly active antiretroviral therapy
    Wolosin, RJ
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2005, 16 (05): : 16 - 25
  • [28] HIV-associated bacteremia: How it has changed in the highly active antiretroviral therapy (HAART) era
    Tumbarello, M
    Tacconelli, E
    Donati, KD
    Citton, R
    Leone, F
    Spanu, T
    Cauda, R
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (02) : 145 - 151
  • [29] Dilated cardiomyopathy in two adult human immunodeficiency positive (HIV+) patients possibly related to highly active antiretroviral therapy (HAART)
    Breuckmann, F
    Neumann, T
    Kondratieva, J
    Wieneke, H
    Ross, B
    Nassenstein, K
    Barkhausen, J
    Kreuter, A
    Brockmeyer, N
    Erbel, R
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2005, 10 (09) : 395 - 399
  • [30] Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma
    Toffoli, G
    Corona, G
    Cattarossi, G
    Boiocchi, M
    Di Gennaro, G
    Tirelli, U
    Vaccher, E
    ANNALS OF ONCOLOGY, 2004, 15 (12) : 1805 - 1809